CAMP4 Therapeutics Corporation Common Stock
Symbol: CAMP (NASDAQ)
2.83
▲ (42.16%) 0.839
Company Description:
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.
Key Stats
- Today's Open: $3.07
- Today's High: $6.872
- Today's Low: $1.871
- Today's Volume: 33.48M
- Yesterday Close: $1.99
- Yesterday High: $2.01
- Yesterday Low: $1.65
- Yesterday Volume: 322.01K
- Last Min Volume: 47.69K
- Last Min High: $2.885
- Last Min Low: $2.827
- Last Min VWAP: $2.8502
Company Profile
- Name: CAMP4 Therapeutics Corporation Common Stock
- Website: https://www.camp4tx.com
- Listed Date: 2024-10-11
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001736730
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $33.27M
- Round Lot: 100
- Outstanding Shares: 20.16M
- Asset Type: CS
RECENT FILINGS FOR CAMP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-13 | 8-K | View |
| 2025-05-16 | 8-K | View |
| 2025-05-14 | SCHEDULE 13G | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-30 | ARS | View |
| 2025-04-30 | DEFA14A | View |
| 2025-04-30 | DEF 14A | View |
| 2025-04-11 | 3/A | View |
Latest News on CAMP